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Solid dosage forms, such as tablets, are widespread in practice. This is due to the
ease of administration and capability of mass production by the pharmaceutical
industry. Tablet formulation consists of the active ingredient along with fillers that
serve various functions in the product. Tablets are prepared on machines known
as presses. Material to be compacted is ready by either dry or wet methods. The
United States Pharmacopeia lists tests to be performed on the finished products.
A description of tablets, their characteristics, preparation, and quality control
tests applied to them is the subject of this brief review.

Introduction
As a solid dosage form, tablets are prepared from dry powders containing
pharmacologically active and inert ingredients. Most drug products available
on the market are found in the form of tablets. Tablets are found on the
market in different shapes, weight, colors, disintegration time, dissolution
time, and for various routes of administration [1]. The oral tablets are
usually easily swallowed and provide either an immediate drug action or a
sustaining effect. In addition to the Active Pharmaceutical Ingredient (API),
a tablet formulation may contain one or more of the following essential
parts: Diluents, binders, lubricants, glidants, anti-adherents, disintegrating
substances, coloring agents, flavoring and sweetening agents, and absorbents
[2]. The instrument that forms powders into tablets is known as a tablet press.
Tablets may be prepared either using dry methods or by wet granulation
[3]. In this paper, the basic ingredients that are commonly found in tablets
are briefly reviewed along with quality control tests performed on the
finished product. The objective of this paper is to present the reader who
is not familiar with tablet formulations the basic information available on
this dosage form.

Ingredients
Table 1 summarizes and provides examples of ingredients that are commonly
found in tablet formulations [4,5].
The bulk of the tablet formulation is made of diluents, also known as
bulking agents. Microcrystalline cellulose (Avicel®) is commonly found in
formulations as well as lactose. Starch from corn, rice, or wheat is also a
possible bulking material for tablets. A couple of sugars, sorbitol, and mannitol
may be found in tablets formulation serving as diluents. Avicel® is useful
in tablets that are formulated by direct compression because it possesses
binding and disintegrating properties. Other directly compressible vehicles
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being compressed. They achieve this by reducing inter particle
friction. Corn starch in concentrations of 5-10% w/w can
act as a glidant. Formulators add anti-adherents to the tablet
formulations to prevent the material from sticking to the walls
of the tablet press. Talcum powder is one of such agents and is
used in concentrations of 5% w/w. Lubricants, glidants, and
anti-adherents are added and mixed with the granulation just

are calcium phosphate, spray-dried lactose, and anhydrous
lactose. There also exist pre-blended vehicles where the API
is added directly to the dry powder vehicle and compressed
as is. Sta-Rx 1500 is an example of such as a vehicle with selfbinding and disintegrating properties. An interesting diluent
for tablets is Emdex® which is hydrolyzed starch. Emdex® may
be used whenever greater strength in tablets is desirable [4].
Tablet Ingredients

Examples

Diluent

Calcium Phosphate; Carboxymethylcellulose Calcium; Cellulose; Dextrin; Lactose; Microcrystalline
Cellulose; Pregelatinized Starch; Sorbitol; Starch

Binders

Acacia; Alginic Acid; Carboxymethylcellulose; Cellulose; Dextrin; Gelatin; Liquid Glucose;
Magnesium Aluminum Silicate; Maltodextrin; Methylcellulose; Povidone; Sodium Alginate;
Starch; Zein

Lubricants

Calcium Stearate; Glyceryl Palmitostearate; Magnesium Oxide; Poloxamer; Polyvinyl Alcohol;
Sodium Benzoate; Sodium Lauryl Sulfate; Sodium Stearyl Sulfate; Stearic Acid; Talc; Zinc Stearate

Glidants

Magnesium Trisilicate; Cellulose; Starch; Talc; Tribasic Calcium Phosphate

Anti-adherents

Corn Starch; Metallic Stearate; Talc

Disintegrants

Alginic Acid; Carboxymethylcellulose; Cellulose; Colloidal Silicon Dioxide; Croscarmellose
Sodium; Crospovidone; Potassium Polacrilin; Povidone

Coloring Agents

FD&C or D&C Dyes or Lake Pigments

Flavoring Agents

Ethyl Maltol; Ethyl Vanillin; Menthol; Vanillin

Absorbents

Kaolin; Magnesium Aluminum Silicate; Tricalcium Phosphate
Table 1: Commonly added ingredients in tablet formulations.

Although the diluent has its cohesiveness and perhaps can
hold the powder particles together to form a tablet, binders
are often used to ensure that tablets maintain their shape
throughout their life cycle (i.e., from manufacturing to the use
by patients). Binders act as a glue adding to the cohesiveness
existing between solid particles. During formulations, binders
are commonly added moist rather than in their dry form. The
reason being is that the efficiency of binding the solid particles
is enhanced in the presence of water. Exceptions to this do
exist. For example, tragacanth gum is a better binder when
added in its dry form than when it is moist. Acacia dispersion
in water (10% w/w) is a suitable binder when mannitol is used
as a diluent. A 10% solution of gelatin in water also serves as
a binder, and so do syrups (50% to 65% w/w of sucrose in
water). Although starch is considered a diluent when found
in relatively large amount in the tablet formulation, it can
also work as a binder after hydrating it with water (2% w/w).
Colloidal guar gum dispersions in water may be used for
binding solid particles as well [4-6].
Lubricants play an important role in tablet formulations as they
reduce the friction between the tablet formulation and the tablet
press walls, preventing ware and tare. Examples of lubricants
are magnesium stearate and silicon dioxide. Lubricants are
found in concentrations less than 1% w/w. Glidants on the
other hand help improve the flow characteristics of the material
Submit Manuscript

before compression [1-6].
Disintegrants are added to the formulation to allow the tablet
to break apart upon contact with water. These agents tend to
swell when they encounter water and thus break apart the
tablet and cause it to disintegrate. Cellulosic materials and
natural gums, as well as starch, may be used to function in
this capacity. The typical concentration of disintegrants in
formulations is between 0.5% to 5% [2,4,6].
The inclusion of absorbents in a tablet formulation is necessary
if the product contains a substance with a high affinity to water.
Hygroscopic materials, if present, render the blend wet and
difficult to handle during manufacture. Silicon dioxide can
absorb excess moisture and remain a dry powder. Examples of
other absorbents are kaolin, bentonite, dry starch, tricalcium
phosphate, Veegum® (colloidal magnesium aluminum silicate),
magnesium oxide, and magnesium carbonate [4].
Coloring agents may be employed in tablet formulations
to render the tablet aesthetically appealing and to perhaps
distinguish one product from another by the color of the
tablet. However, coloring agents may also serve to establish
visual homogeneity of the blend once the color is uniformly
distributed in the mixture. During wet granulation, the dye
is dissolved or dispersed in the binder solution and added
to the mix along with the binder. FD&C or D&C dyes or

Journal of Pharmacy Practice and Pharmaceutical Sciences [ISSN: 2652-2536]

.02.

Citation: Al-Achi A (2019) Tablets: A Brief Overview. J Pharm Pract Pharm Sci 2019(1): 50-53. DOI:10.33513/PPPS/1901-10

Lake pigments may be used in the tablet formulation. Lake
pigments, unlike dyes, are insoluble in water and they color
by dispersion. Lake pigments are more suited to color solid
dosage forms such as tablets [1,4].
Flavoring oils are needed for chewable tablets. The oil is
generally added in a dry form such as spray-dried beadlets.
An excess amount of the flavor oil can interfere with the flow
ability of the granulation, and thus its concentration in the
blend is kept at 0.5% or less [4,6].
Ingredients that may be included in a tablet formulation are
often chosen by experimental and scientific knowledge in the
field of manufacturing solid dosage forms as well by applying
mathematical modeling such as the Design of Experiment
(DoE). The utilization of DoE in finding the best composition
of a tablet formulation may be achieved by choosing a
proper design, defining a study domain, and by conducting
experimentation. Among the useful designs in this respect are
mixtures design and custom design (also known as D-optimal
design). Whereas the latter allows more flexibility in choosing
the appropriate amount of ingredients to be tested, the former
is applied with the constraint that the sum of ingredients for a
given formulation must be 100%. Statistical programs such as
JMP Statistical Discovery Software (SAS Institute, Cary, NC)
may be used to run the DoE planning and analysis. When
applying the DoE on tablet formulation, the operator has to
define at least one measurable outcome, define the ranges of the
quantity of each ingredient to be tested within the formulation,
and finally determine the number of runs (experiments) that
should be performed. Each experiment in the DoE table then
is executed by the operator and the value of the outcome
is recorded. Once all the data are collected, the results are
analyzed and the best composition for the tablet formulation is
then obtained. As a proof of concept, this formulation is then
prepared multiple times and subjected to further testing in order
to define its suitability for manufacturing. The application of
DoE in formulation is currently considered to be the state of
art in preparing dosage forms.

Tablet Preparation
As mentioned above, tablets are made on machines known
as presses. These can be single-punch or multi-stationary
presses. The main components of a press are the hopper,
guiding scrapers, dies, punches, and cams. The material to
be tableted is placed in the hopper and with the help of the
feeders is distributed into the die cavity. The upper punch
descends with force guided by cams to compress the material
into a tablet. The formed tablet is then released from the die
cavity with the movement of the lower punch. The position

of the lower punch inside the die determines the size of the
die cavity. Thus, dies shape and control the size of the tablets.
Punches also influence the shape of the tablets as well. Some
tablets are shaped like capsules for easy swallowing the unit
[4]. These are known as caplets.
Two methods of making tablets are recognized. These are the
dry methods and wet methods. The dry methods are of two
types, direct compression, and granulation by compression. The
first method relies on the presence of a directly compressible
vehicle. The API is added to the vehicle and compressed.
Granulation by compression includes formation of a large,
poorly formed tablets (known as slugs), followed by gridding
the slugs into granules. The resulting granules are made into
slugs and then one more time made into granules. These
final granules are then compressed into tablets. Due to twice
formation of granules and slugs, the cohesive forces in the
mixture is strong enough, and thus binders are not needed
in the formulation. Moreover, since no water is used during
the preparation of slugs or granules, there is also no need for
drying steps [1-3].
In wet granulation methods, the API is mixed homogeneously
with other fillers that include half the quantity of disintegrants
and then wetted with an aqueous dispersion of the binder
containing the dye. Following proper mixing, the wet mass
is then forced through sieve openings to form granules. The
resulting granules are dried and passed again through sieve
openings smaller than the ones used before. Lubricants, glidants,
anti-adherents, and half the quantity of disintegrants are added
to the granules and mixed. The resulting dry granulation
mixture is finally compressed into tablets. As a rule, small
tablets require small granules and large tablets need large
granules [1-3].

Quality Control Tests
The United States Pharmacopeia (USP) lists several tests to be
performed on the finished tablets to assure their suitability to
be used in therapy [1,2]. These tests are also essential to ensure
that various batches of the same products produce consistent
results on these tests. For more details on these tests, the reader
is referred to the USP 41/NF 36.
Tablet breaking force tests the hardness of the tablet. Too
much binder in the formulation produces hard tablets. If the
tablet is soft, it can be damaged easily by handling, packaging,
or shipping. On the other hand, too hard tablets cannot
disintegrate easily, and the bioavailability of the API from the
tablets is significantly affected.
Friability test examines the amount of material lost from tablets
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after subjecting them to fall from a 6-inch hight while they are
rotated 100 times (25 rotations/minute for 4 minutes). Tablets
(20) are weighed before the test and immediately following
the rotation. For the batch of tablets to pass this test, the loss
in their weight should be less than 1%. In the case of capping
(loss of top or bottom of the tablet) during the friability test,
the tablets fail this test regardless of the weight loss.
Disintegration test is required to assure that the tablets can
break apart when they contact aqueous fluids. The test utilizes
a basket made of a mesh screen at its bottom and six columns
where the tablets are placed, one tablet per column. The basket
is then immersed in 900 mL of water (37°C) and moved up
and down with the help of a motor that controls a handler
where the basket is attached to it. For most immediate release
tablets, their disintegration time is within a few minutes.
Among the important tests to be performed on the finished
tablets is the dissolution test. The test utilizes six round-bottom
flasks that are placed in a water bath for temperature control
(37°C). One tablet is placed in each flask containing the test
medium (usually water, 900 mL). It is expected that at a
minimum 70-75% of the API is dissolved in the test medium
within 30-45 minutes. In practice, for most immediate release
tablets, a minimum of 90% of API is dissolved within 30
minutes.
Weight variation test requires the selection of 10 tablets from
the tablets batch and pulverizing them together in a mortar.
A weight equivalent of a single tablet is then taken from the
powder mixture and analyzed for its content of API. This
amount is then compared with the labeled amount of the
API in the product.

However, the API content in 10 different random tablets is
determined individually.

Conclusion
As a solid dosage form, tablets are popular among patients and
practitioners alike as they provide a means of self-administration.
The formulation of a tablet contains, in addition to the API,
various substances to assure proper delivery of the API to the
patient. Quality control tests on the finished products are
required and follow USP standards.
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